Immuno-oncology approaches in uveal melanoma: tebentafusp and beyond by Gerard, C., Shum, B., Nathan, P., Turajlic, S.

Get full text

TCR sequencing: applications in immuno-oncology research by Sanromán, Á.F., Joshi, K., Au, L., Chain, B., Turajlic, S.

Get full text

Severe cutaneous adverse reaction following COVID‐19 vaccination and immunotherapy: a second hit? by Hussain, K., Kawsar, A., Weir, J., Au, L., Turajlic, S., Larkin, J., Fearfield, L.

Get full text

Predicting development of ipilimumab-induced hypophysitis: utility of T4 and TSH index but not TSH by Siddiqui, M. S., Lai, Z. M., Spain, L., Greener, V., Turajlic, S., Larkin, J., Morganstein, D. L.

Get full text

WHO 2022 classification of penile and scrotal cancers: updates and evolution by Menon, S, Moch, H, Berney, DM, Cree, IA, Srigley, JR, Tsuzuki, T, Compérat, E, Hartmann, A, Netto, G, Rubin, MA, Gill, AJ, Turajlic, S, Tan, PH, Raspollini, MR, Tickoo, SK, Amin, M B

Get full text

Cutaneous toxicities in patients with melanoma receiving checkpoint inhibitor therapy: a retrospective review. The experience of a single large specialist institution by Edwards, C. L., Comito, F., Agraso Busto, S., Harland, C., Turajlic, S., Larkin, J., Heelan, K., Fearfield, L.

Get full text

Generalized melanosis and melanuria in a patient with metastatic melanoma by Perez, A., Turajlic, S., Szyszko, T., O'Doherty, M., Calonje, E., Harries, M., Acland, K.

Get full text

Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution by Hiley, Crispin T., Wilson, Gareth A., Birkbak, Nicolai J., Veeriah, Selvaraju, Herrero, Javier, Swanton, Charles, Swanton, Charles, Czyzewska-Khan, Justyna, Gorman, Pat, Wilson, Gareth, Watkins, Thomas B.K., McGranahan, Nicholas, Mitter, Richard, Escudero, Mickael, Rowan, Andrew, Xu, Hang, Turajlic, Samra, Stone, Richard Kevin, Denner, Tamara, Costa, Marta, Phillimore, Ben, Joshi, Kroopa, Furness, Andrew, Ben Aissa, Assma, Wong, Yien Ning Sophia, Quezada, Sergio, Hartley, John A., Lowe, Helen L., Herrero, Javier, Lawrence, David, Falzon, Mary, Borg, Elaine, Marafioti, Teresa, Janes, Sam M., Thakrar, Ricky, Papadatos-Pastos, Dionysis, Choudhary, Junaid, Califano, Raffaele, Taylor, Paul, Crosbie, Phil, Moss, Stuart, Idries, Faiza, Bishop, Paul, Chaturved, Anshuman, Quinn, Anne Marie, Doran, Helen, Leek, Angela, Blackhall, Fiona, Chemi, Francesca, Gulati, Sakshi, Naidu, Babu, Trotter, Simon, Bellamy, Mary, Bancroft, Hollie, Middleton, Gary, Shaw, Jacqui A., Le Quesne, John, Rathinam, Sridhar, Monteiro, William, Marshall, Hilary, Riley, Joan, Primrose, Lindsay, Anand, Girija, Nicolson, Marianne, Palmer, Shirley, Buchan, Keith, Chetty, Mahendran, Edwards, Alison, Morgan, Fiona, Davies, Helen, Verjee, Azmina, MacKenzie, Mairead, Hackshaw, Allan, Smith, Sean, Alzetani, Aiman, Shaw, Emily, Rice, Alexandra, Raubenheimer, Hilgardt, Proli, Chiara, Cufari, Maria Elena, Bhayani, Harshil, Bakar, Yusura, Mensah, Natalie, Ambrose, Lyn, Devaraj, Anand, Chavan, Hema, Lau, Kelvin, Sheaff, Michael, Schmid, Peter, Ezhil, Veni, Ismail, Babikir, Irvin-sellers, Melanie, Prakash, Vineet, Horey, Tracey, Hill, Jennifer, Suvarna, Kim, Keerio, Allah Dino, Feeney, Sarah, Asante-Siaw, Julius, Dessimoz, Christophe

Get full text

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution by Abbosh, Christopher, Birkbak, Nicolai J, Wilson, Gareth A, Jamal-Hanjani, Mariam, Constantin, Tudor, Salari, Raheleh, Le Quesne, John, Moore, David A, Veeriah, Selvaraju, Rosenthal, Rachel, Marafioti, Teresa, Kirkizlar, Eser, Watkins, Thomas B K, McGranahan, Nicholas, Ward, Sophia, Martinson, Luke, Riley, Joan, Fraioli, Francesco, Zambrana, Francisco, Endozo, Raymondo, Bi, Wenya Linda, Fennessy, Fiona M, Sponer, Nicole, Johnson, Diana, Laycock, Joanne, Shafi, Seema, Czyzewska-Khan, Justyna, Rowan, Andrew, Chambers, Tim, Matthews, Nik, Turajlic, Samra, Hiley, Crispin, Lee, Siow Ming, Forster, Martin D, Ahmad, Tanya, Falzon, Mary, Borg, Elaine, Lawrence, David, Hayward, Martin, Kolvekar, Shyam, Panagiotopoulos, Nikolaos, Janes, Sam M, Thakrar, Ricky, Ahmed, Asia, Blackhall, Fiona, Summers, Yvonne, Hafez, Dina, Naik, Ashwini, Ganguly, Apratim, Kareht, Stephanie, Shah, Rajesh, Joseph, Leena, Crosbie, Phil A, Naidu, Babu, Middleton, Gary, Langman, Gerald, Trotter, Simon, Nicolson, Marianne, Remmen, Hardy, Kerr, Keith, Chetty, Mahendran, Gomersall, Lesley, Fennell, Dean A, Nakas, Apostolos, Rathinam, Sridhar, Anand, Girija, Khan, Sajid, Russell, Peter, Ezhil, Veni, Ismail, Babikir, Irvin-Sellers, Melanie, Prakash, Vineet, Lester, Jason F, Kornaszewska, Malgorzata, Attanoos, Richard, Adams, Haydn, Oukrif, Dahmane, Akarca, Ayse U, Hartley, John A, Lowe, Helen L, Lock, Sara, Iles, Natasha, Bell, Harriet, Ngai, Yenting, Elgar, Greg, Szallasi, Zoltan, Schwarz, Roland F, Herrero, Javier, Stewart, Aengus, Quezada, Sergio A, Peggs, Karl S, Van Loo, Peter, Dive, Caroline, Lin, C Jimmy, Rabinowitz, Matthew, Aerts, Hugo J W L, Hackshaw, Allan, Shaw, Jacqui A, Zimmermann, Bernhard G, Swanton, Charles

Get full text

Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium by Amaria, Rodabe N, Menzies, Alexander M, Burton, Elizabeth M, Scolyer, Richard A, Tetzlaff, Michael T, Antdbacka, Robert, Ariyan, Charlotte, Bassett, Roland, Carter, Brett, Daud, Adil, Faries, Mark, Fecher, Leslie A, Flaherty, Keith T, Gershenwald, Jeffrey E, Hamid, Omid, Hong, Angela, Kirkwood, John M, Lo, Serigne, Margolin, Kim, Messina, Jane, Postow, Michael A, Rizos, Helen, Ross, Merrick I, Rozeman, Elisa A, Saw, Robyn P M, Sondak, Vernon, Sullivan, Ryan J, Taube, Janis M, Thompson, John F, van de Wiel, Bart A, Eggermont, Alexander M, Davies, Michael A, Andrews, Miles C, Berry, Donald A, Block, Matthew S, Boland, Genevieve M, Bollin, Kathryn B, Carlino, Matteo S, Carvajal, Richard D, Cohen, Jonathan, Davar, Diwakar, Delman, Keith A, Dummer, Reinhard, Farwell, Michael D, Fisher, David E, Fusi, Alberto, Glitza, Isabella C, de Gruijl, Tanja D, Gyorki, David E, Hauschild, Axel, Hieken, Tina J, Larkin, James, Lawson, David H, Lebbe, Celeste, Lee, Jeffrey E, Lowe, Michael C, Luke, Jason J, McArthur, Grant A, McDermott, David F, McQuade, Jennifer L, Mitchell, Tara C, Petrella, Teresa M, Prieto, Peter A, Puzanov, Igor, Robert, Caroline, Salama, April K, Sandhu, Shaneen, Schadendorf, Dirk, Shoushtari, Alexander N, Sosman, Jeffrey A, Swetter, Susan M, Tanabe, Ken K, Turajlic, Samra, Tyler, Douglas S, Woodman, Scott E, Wright, Frances C, Zager, Jonathan S, Ascierto, Paolo A, Spillane, Andrew J, van Akkooi, Alexander C J, Wargo, Jennifer A, Blank, Christian U, Tawbi, Hussein A, Long, Georgina V

Get full text

Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors by Lesko, Marta H., Miranda Rota, Enrique, Dahan, Rony, Georgiou, Andrew, Sledzinska, Anna, Werner Sunderland, Mariana, Nicol, David, Beers, Stephen A., Wotherspoon, Andrew, Hayes, Andrew, Stares, Mark, Pickering, Lisa, Rudman, Sarah, Veeriah, Selvaraju, Shafi, Seema, Laycock, Joanne, Bosshard-Carter, Leticia, Goh, Gerald, Rosenthal, Rachel, Hynds, Robert E., Birkbak, Nicolai J., McGranahan, Nicholas, Mitter, Richard, Stewart, Aengus, Rowan, Andrew, Turajlic, Samra, Abbosh, Christopher, Goldman, Jacki, Denner, Tamara, Ward, Sophia, Costa, Marta, Lowe, Helen L., Lawrence, David, Kolvekar, Shyam, Falzon, Mary, Simeon, Celia, Hector, Gemma, Novelli, Marco, Forster, Martin, Papadatos-Pastos, Dionysis, Carnell, Dawn, Navani, Neal, Ahmed, Asia, Taylor, Magali, Choudhary, Junaid, Taylor, Paul, Rammohan, Kendadai, Fontaine, Eustace, Booton, Richard, Moss, Stuart, Idries, Faiza, Joseph, Leena, Moore, Katrina, Waddington, Rachael, Novasio, Juliette, Blackhall, Fiona, Rogan, Jane, Tugwood, Jonathan, Rothwell, Dominic G., Pierce, Jackie, Gulati, Sakshi, Kerr, Amy, Webb, Joanne, Moore, David, Monteiro, William, Marshall, Hilary, Nelson, Louise, Amadi, Anita, Remmen, Hardy, Miller, Joy, Morgan, Fiona, Kornaszewska, Malgorzata, Bell, Harriet, Smith, Sean, Johnson, Benjamin, Lim, Eric, Barbosa, Monica Tavares, Bowman, Alex, Ronquillo, John Carlo, Bhayani, Harshil, Hamilton, Morag, Bakar, Yusura, Mensah, Natalie, Buderi, Silviu, Finch, Jonathan, Green, Sophie, Nicholson, Andrew G., Lau, Kelvin, Schmid, Peter, Conibear, John, Ezhil, Veni, Ismail, Babikir, Prakash, Vineet, Horey, Tracey, Swanton, Charles, Chester, Kerry A., Ravetch, Jeffrey V., Marafioti, Teresa, Peggs, Karl S., Quezada, Sergio A.

Get full text

Using the Senior Adult Oncology Programme Questionnaire to Screen Skin and Renal Cancer Patients by Cunningham, N., Fouda, M., Vengadasalam, V., Day, K., Macwana, R., Nobbs, J., Furness, A., Pickering, L., Turajlic, S., Larkin, J., Battisti, N.M.L., Young, K.

Get full text

PCN206 PATIENT-REPORTED REAL-WORLD TREATMENT PATTERNS FOR MELANOMA IN THE UK MEASURED USING A DIGITAL 'BRING YOUR OWN DEVICE' PLATFORM by Larkin, J., Cannon, D., Nuttall, G., Au, L., Hunter, N., Spain, L., Turajlic, S., Åkesson, C., Llewellyn, S., Nixon, A., Kousoulakou, H., Larkin, M., Wiseman, T.

Get full text

179P Early proof of concept of safety and clinical activity of clonal neoantigen-reactive T cells (cNeT) by Forster, M.D., Cave, J., Greystoke, A., Plummer, R., Spicer, J., Thistlethwaite, F., Turajlic, S., Craig, A., Newton, K., Saggese, M., Quezada, S., Peggs, K.

Get full text

Real-World EQ-5D-5L Utility Values In Patients With Melanoma Derived Using A Digital ‘Bring Your Own Device’ Platform by Larkin, J, Nuttal, G, Cannon, D, Au, L, Spain, L, Hunter, N, Turajlic, S, Nixon, A, Kousoulakou, H, Larkin, M, Wiseman, T

Get full text

Taking The Burden Out Of Symptom Reporting In Patients With Melanoma Using A Digital Real-World Evidence Platform by Au, L, Nuttal, G, Cannon, D, Spain, L, Hunter, N, Turajlic, S, Nixon, A, Kousoulakou, H, Larkin, M, Larkin, J, Wiseman, T

Get full text

PCN169 - Taking The Burden Out Of Symptom Reporting In Patients With Melanoma Using A Digital Real-World Evidence Platform by Au, L, Nuttal, G, Cannon, D, Spain, L, Hunter, N, Turajlic, S, Nixon, A, Kousoulakou, H, Larkin, M, Larkin, J, Wiseman, T

Get full text

PCN154 - Real-World EQ-5D-5L Utility Values In Patients With Melanoma Derived Using A Digital ‘Bring Your Own Device’ Platform by Larkin, J, Nuttal, G, Cannon, D, Au, L, Spain, L, Hunter, N, Turajlic, S, Nixon, A, Kousoulakou, H, Larkin, M, Wiseman, T

Get full text

87P Infliximab use in patients with checkpoint inhibitor toxicities: A tertiary centre experience by Zhang, S.H., Cartwright, E., Mullings, S., Ferro Lopez, L.F., Cunningham, D., Chau, I., Starling, N., Popat, S., O'Brien, M.E.R., Bhosle, J., Minchom, A.R., Davidson, M., Tokaca, N., Lalondrelle, S., Pickering, L.M., Furness, A., Turajlic, S., Larkin, J., José, R., Young, K.

Get full text

217 Identifying the metastatic subclone by exhaustive sampling of primary and metastasis in clear cell renal cell carcinoma (ccRCC) pair by Soultati, A, O'Brien, T, Challacombe, B.J, Nicol, D, Horswell, S, Xu, H, Rowan, A.J, Lopez, J.I, Stares, M, Chandra, A, Chowdhury, S, Rudman, S, Matthews, N, Larkin, J, Turajlic, S, Swanton, C

Get full text